AN2 Therapeutics, Inc. (ANTX)
5.74
-0.24
(-4.01%)
USD |
NASDAQ |
Sep 09, 11:41
AN2 Therapeutics Market Cap : 208.41M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 217.13M |
| September 04, 2026 | 213.86M |
| September 03, 2026 | 216.04M |
| September 02, 2026 | 216.04M |
| September 01, 2026 | 198.97M |
| August 31, 2026 | 201.51M |
| August 28, 2026 | 202.60M |
| August 27, 2026 | 208.41M |
| August 26, 2026 | 200.79M |
| August 25, 2026 | 205.51M |
| August 24, 2026 | 204.42M |
| August 21, 2026 | 210.95M |
| August 20, 2026 | 210.23M |
| August 19, 2026 | 216.40M |
| August 18, 2026 | 216.76M |
| August 17, 2026 | 208.05M |
| August 14, 2026 | 217.49M |
| August 13, 2026 | 217.13M |
| August 12, 2026 | 228.02M |
| August 11, 2026 | 213.13M |
| August 10, 2026 | 214.58M |
| August 07, 2026 | 215.31M |
| August 06, 2026 | 218.79M |
| August 05, 2026 | 210.16M |
| August 04, 2026 | 213.75M |
| Date | Value |
|---|---|
| August 03, 2026 | 200.80M |
| July 31, 2026 | 192.52M |
| July 30, 2026 | 191.80M |
| July 29, 2026 | 180.65M |
| July 28, 2026 | 169.13M |
| July 27, 2026 | 177.41M |
| July 24, 2026 | 177.05M |
| July 23, 2026 | 177.05M |
| July 22, 2026 | 175.97M |
| July 21, 2026 | 179.93M |
| July 20, 2026 | 172.73M |
| July 17, 2026 | 168.41M |
| July 16, 2026 | 168.05M |
| July 15, 2026 | 168.05M |
| July 14, 2026 | 171.29M |
| July 13, 2026 | 163.73M |
| July 10, 2026 | 161.94M |
| July 09, 2026 | 166.61M |
| July 08, 2026 | 158.70M |
| July 07, 2026 | 154.74M |
| July 06, 2026 | 158.70M |
| July 02, 2026 | 159.06M |
| July 01, 2026 | 169.13M |
| June 30, 2026 | 174.17M |
| June 29, 2026 | 181.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 16.96M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 577.58M |
| Fulcrum Therapeutics, Inc. | 289.50M |
Market Cap Related Metrics
| Price to Book Value | 2.745 |
| Price | 5.74 |
| Earnings Yield | -18.70% |